← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 27, 2019Last known activity
Jan 16, 2024
Timeline
2010s
- Jan 1, 2017
Sanotize Research and Development Corp.— Founded
Drugs by trial phase (2 distinct, 9 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Recent trials (14)
- NCT06264141Lead sponsorPhase 2Jan 16, 2024
- NCT06264141OfficialPhase 2Jan 16, 2024
- NCT06120816Lead sponsorPhase 1Dec 31, 2023
- NCT06120816Study directorPhase 1Dec 31, 2023
- NCT06120816OfficialPhase 1Dec 31, 2023
- NCT05877313Study directorPhase 2Aug 2, 2023
- NCT05877313Lead sponsorPhase 2Aug 2, 2023
- NCT05109611Lead sponsorPhase 3Dec 20, 2021
- NCT05109611Study directorPhase 3Dec 20, 2021
- NCT05599919Lead sponsorPhase 3Nov 1, 2021
- NCT04755647Lead sponsorPhase 1/Phase 2Feb 23, 2021
- NCT04443868Lead sponsorPhase 2Jan 31, 2021
- NCT04337918Lead sponsorPhase 2Apr 6, 2020
- NCT04163978Lead sponsorPhase 2Oct 27, 2019
Details
- Founded
- Vancouver, CA Jan 1, 2017
- Last known activity
- Jan 16, 2024